Eris Lifesciences has launched DEMELAN NEXA Serum, targeting evolving needs in pigmentation and melasma management. The formulation reflects growing scientific understanding of pigmentation biology and treatment pathways. It aims to support dermatologists with a more comprehensive approach to recurrent melasma and photoaging. Addressing gaps in current treatments Melasma remains a persistent challenge in dermatology, with high recurrence rates reported in ...